This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
PLXDC1
Reactivity: Human, Mouse, Rat
WB, ELISA, IHC (p), IF
Host: Rabbit
Polyclonal
unconjugated
Application Notes
WB: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Halder, Ossendorf, Maran, Yaszemski, Bolander, Fuchs, Sarkar: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).
Yamaji, Yoshida, Ishikawa, Sengoku, Sato, Yoshida, Kuwahara, Ohuchida, Oki, Enaida, Fujisawa, Kono, Ishibashi: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, (2008) (PubMed).
Fuchs, Mahlum, Halder, Maran, Yaszemski, Bode, Bolander, Sarkar: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." in: Gene, Vol. 399, Issue 2, pp. 137-43, (2007) (PubMed).
Nanda, Buckhaults, Seaman, Agrawal, Boutin, Shankara, Nacht, Teicher, Stampfl, Singh, Vogelstein, Kinzler, St Croix: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." in: Cancer research, Vol. 64, Issue 23, pp. 8507-11, (2004) (PubMed).